I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
The Surrey Heartland Integrated Care System Area Prescribing Committee have agreed to adopt the SERMOG high-cost drugs pathway.for adiults with psoriasis
The PCN recommends Ixekizumab as a treatment option for treating moderate to severe plaque psoriasis in line with NICE and associated treatment pathways. Prescribing will be by hospital specialists only, in line with NICE TA442 using Blueteq initiation and continuation forms. Ixekizumab will be considered RED on the traffic light system.
Other Indications
Below are listed other indications that Ixekizumab is used to treat.
